Literature DB >> 22527141

Successful childbearing in two women with rheumatoid arthritis and a history of miscarriage after etanercept treatment.

Ikumi Natsumi1, Yoshihiro Matsukawa, Kohji Miyagawa, Hitomi Kodaira, Toshitake Tanaka, Akira Horikoshi, Jin Takeuchi, Masami Takei, Mamoru Maejima, Jun Akimoto.   

Abstract

Two women with rheumatoid arthritis who had experienced miscarriages became pregnant while they were under etanercept treatment. One stopped etanercept after 3 weeks with increased doses of prednisolone, and the other restarted etanercept at a half doses 3 months later. They delivered a healthy baby at full term, and no problems in both expecting mothers and babies were observed. The use of etanercept in patients with rheumatoid arthritis seemed safe for pregnant mothers and their fetuses.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22527141     DOI： 10.1007/s00296-012-2433-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  16 in total

1.  [Etanercept and pregnancy].

Authors:  I Otermin; G Elizondo; J Zabaleta; A Amigot
Journal:  An Sist Sanit Navar       Date:  2007 Sep-Dec       Impact factor: 0.829

2.  Successful ovulation induction, conception, and normal delivery after chronic therapy with etanercept: a recombinant fusion anti-cytokine treatment for rheumatoid arthritis.

Authors:  E S Sills; M Perloe; M J Tucker; C R Kaplan; G D Palermo
Journal:  Am J Reprod Immunol       Date:  2001-11       Impact factor: 3.886

3.  Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register.

Authors:  Suzanne M M Verstappen; Yvonne King; Kath D Watson; Deborah P M Symmons; Kimme L Hyrich
Journal:  Ann Rheum Dis       Date:  2011-02-28       Impact factor: 19.103

4.  Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis.

Authors:  Jeffry A Katz; Christian Antoni; Gregory F Keenan; Deirdre E Smith; Stephen J Jacobs; Gary R Lichtenstein
Journal:  Am J Gastroenterol       Date:  2004-12       Impact factor: 10.864

5.  [Treatment of patients with rheumatoid arthritis who desire to become pregnant--successful pregnancy in three cases treated with etanercept].

Authors:  Atsuko Murashima
Journal:  Nihon Rinsho       Date:  2008-11

6.  Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study.

Authors:  Yaël A de Man; Johanna M W Hazes; Hugo van der Heide; Sten P Willemsen; Christianne J M de Groot; Eric A P Steegers; Radboud J E M Dolhain
Journal:  Arthritis Rheum       Date:  2009-11

7.  A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database.

Authors:  John D Carter; Anil Ladhani; Louis R Ricca; Joanne Valeriano; Frank B Vasey
Journal:  J Rheumatol       Date:  2009-03       Impact factor: 4.666

8.  Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum.

Authors:  A Murashima; N Watanabe; N Ozawa; H Saito; K Yamaguchi
Journal:  Ann Rheum Dis       Date:  2009-11       Impact factor: 19.103

9.  A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment.

Authors:  Naoto Umeda; Satoshi Ito; Taichi Hayashi; Daisuke Goto; Isao Matsumoto; Takayuki Sumida
Journal:  Intern Med       Date:  2010-01-15       Impact factor: 1.271

10.  The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.

Authors:  Eliza F Chakravarty; Deanna Sanchez-Yamamoto; Thomas M Bush
Journal:  J Rheumatol       Date:  2003-02       Impact factor: 4.666
View more
  2 in total

Review 1.  The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis.

Authors:  Carole Guillet; Corsin Seeli; Meienberger Nina; Lara Valeska Maul; Julia-Tatjana Maul
Journal:  Int J Womens Dermatol       Date:  2022-04-13

2.  Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan.

Authors:  Ken Nakajima; Omi Watanabe; Mayumi Mochizuki; Ayako Nakasone; Nobuhiko Ishizuka; Atsuko Murashima
Journal:  Mod Rheumatol       Date:  2016-03-04       Impact factor: 3.023
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.